Trials / Completed
CompletedNCT05967845
Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty
Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty: a Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was performed to compare healing and hearing outcomes of two tympanoplasty techniques, performed for patients with total or subtotal tympanic membrane perforations. The first group underwent temporalis fascia tympanoplasty, augmented with platelet rich fibrin, while the second group underwent cartilage tympanoplasty. preoperative data, operative techniques, and postoperative outcomes were analyzed.
Detailed description
Two groups are included. In the platelet rich fibrin augmented tympanoplasty group, a piece of temporalis fascia is harvested and used as a graft material. A layer of platelet rich fibrin is added to improve healing process. In the cartilage tympanoplasty group, a piece of cartilage is harvested from the patient concha and used for grafting. Both groups will be compared in terms of healing and hearing. Healing is considered successful if an intact tympanic membrane is achieved withing 12 weeks follow up period. Hearing outcomes are analyzed by comparing the preoperative pure tone audiometry values with the postoperative values.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cartilage tympanoplasty | cartilage tympanoplasty procedure entails repairing the tympanic membrane perforation by using a piece of cartilage harvested from the patient's auricle. |
| PROCEDURE | platelet rich fibrin augmented tympanoplasty | platelet rich fibrin augmented tympanoplasty entails performing the traditional tympanoplasty using the tempralis fascia as a grafting material. However, platelet rich fibrin clot is obtained from the patient's own blood, and applied to the graft to enhance healing process. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2023-08-01
- Last updated
- 2023-08-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05967845. Inclusion in this directory is not an endorsement.